Masimirembwa CM - Search Results

1

Establishment of a biobank and pharmacogenetics database of African populations.

Matimba A, Oluka MN, Ebeshi BU, Sayi J, Bolaji OO, Guantai AN, Masimirembwa CM. Matimba A, et al. Among authors: masimirembwa cm. Eur J Hum Genet. 2008 Jul;16(7):780-3. doi: 10.1038/ejhg.2008.49. Epub 2008 Apr 2. Eur J Hum Genet. 2008. PMID: 18382479 No abstract available.

2

Cytochrome P450 pharmacogenetics in African populations: implications for public health.

Dandara C, Swart M, Mpeta B, Wonkam A, Masimirembwa C. Dandara C, et al. Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):769-85. doi: 10.1517/17425255.2014.894020. Epub 2014 Mar 3. Expert Opin Drug Metab Toxicol. 2014. PMID: 24588448 Review.

3

Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.

Matimba A, Del-Favero J, Van Broeckhoven C, Masimirembwa C. Matimba A, et al. Hum Genomics. 2009 Jan;3(2):169-90. doi: 10.1186/1479-7364-3-2-169. Hum Genomics. 2009. PMID: 19164093 Free PMC article.

4

An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.

Soko ND, Chimusa E, Masimirembwa C, Dandara C. Soko ND, et al. Pharmacogenomics J. 2019 Jun;19(3):240-248. doi: 10.1038/s41397-018-0035-3. Epub 2018 Aug 13. Pharmacogenomics J. 2019. PMID: 30100615

5

Pharmacokinetics of rosuvastatin in 30 healthy Zimbabwean individuals of African ancestry.

Soko N, Dandara C, Ramesar R, Kadzirange G, Masimirembwa C. Soko N, et al. Br J Clin Pharmacol. 2016 Jul;82(1):326-8. doi: 10.1111/bcp.12915. Epub 2016 Apr 13. Br J Clin Pharmacol. 2016. PMID: 26910794 Free PMC article. No abstract available.

6

Rolling out Efavirenz for HIV Precision Medicine in Africa: Are We Ready for Pharmacovigilance and Tackling Neuropsychiatric Adverse Effects?

Masimirembwa C, Dandara C, Leutscher PD. Masimirembwa C, et al. OMICS. 2016 Oct;20(10):575-580. doi: 10.1089/omi.2016.0120. Epub 2016 Sep 14. OMICS. 2016. PMID: 27627692 Review.

7

A cost effective RFLP method to genotype Solute carrier organic anion 1B1 (SLCO1B1) c.1929A>C (p.Leu643Phe, rs34671512); a variant with potential effect on rosuvastatin pharmacokinetics.

Soko ND, Masimirembwa C, Dandara C. Soko ND, et al. BMC Res Notes. 2018 Jun 14;11(1):384. doi: 10.1186/s13104-018-3469-4. BMC Res Notes. 2018. PMID: 29898760 Free PMC article.

8

Rosuvastatin pharmacogenetics in African populations.

Soko ND, Masimirembwa C, Dandara C. Soko ND, et al. Pharmacogenomics. 2018 Dec;19(18):1373-1375. doi: 10.2217/pgs-2018-0168. Epub 2018 Nov 6. Pharmacogenomics. 2018. PMID: 30398065 No abstract available.

9

African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.

Rajman I, Knapp L, Morgan T, Masimirembwa C. Rajman I, et al. EBioMedicine. 2017 Mar;17:67-74. doi: 10.1016/j.ebiom.2017.02.017. Epub 2017 Feb 20. EBioMedicine. 2017. PMID: 28237373 Free PMC article.

10

Characterisation of artemisinin-chloroquinoline hybrids for potential metabolic liabilities.

Thelingwani R, Leandersson C, Bonn B, Smith P, Chibale K, Masimirembwa C. Thelingwani R, et al. Xenobiotica. 2016;46(3):234-40. doi: 10.3109/00498254.2015.1070975. Epub 2015 Sep 4. Xenobiotica. 2016. PMID: 26338168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results